HONG KONG, August 2019 — As a medical emergency caused by severe cardiovascular diseases, myocardial infarction (MI) can inflict permanent and life-threatening damage to the heart.
You are here
News
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
San Diego, CA (US), August 2019 — Glioblastoma is an aggressive form of brain cancer that infiltrates surrounding brain tissue, making it extremely difficult to treat with surgery.

WINSTON-SALEM, NC (US), August 2019 – Prostate cancer is the most common cancer in men, with radical prostatectomy as a commonly chosen course of action. The reported rate of erectile dysfunction after prostate surgery for cancer is reportedly as high as 90 percent.
TOKYO (JP), August 2019 — The human liver is a vital organ involved in multiple functions.

SEATTLE, WA (US), August 2019 — Researchers at Fred Hutchinson Cancer Research Center have used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed with several blood disorders, including sickle cell disease and beta-thalassemia.
YOKOHAMA (JP), August 2019 — Scientists have developed an efficient method of successfully generating hair growth in nude mice.
LONDON (UK), August 2019 — A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research published in
CHICAGO, IL (US), July 2-19 — Researchers have discovered how the genetic defect in fragile X syndrome — a type of autism — delays production of neurons (nerve cells) at a critical time in the embryo's brain development.
OAKLAND, CA (US), July 2019 — The California Institute for Regenerative Medicine (CIRM) board has approved investing $19.7 million in four awards in its Translational Research program, which helps promising projects complete the testing needed to begin talking to the US Food and
STANFORD, CA (US), July 2019 — Researchers have uncovered how a genetic mutation contributes to a heart disease known as familial dilated cardiomyopathy. Existing drugs correct the defect in heart cells grown in a petri dish, suggesting a new therapeutic target.